Pharmaceutical companies may try to cap the price hike in future.
Tag: Diagnostic/Medical Research Services
Elon Musk’s Neuralink Demonstrates ‘Telepathic Typing’ in Monkeys
The neuroscience startup says it should be ready for human trials in six months during a…
Elon Musk’s Neuralink Set to ‘Show and Tell’ Latest Brain-Computer Advances at Event
Technique The startup, which aims to help people with neurological conditions or others by decoding brain…
New Alzheimer’s Drug Shows Positive Results but Side Effects
Health Eisai and Biogen’s drug slowed cognitive decline in study volunteers, but many had bleeding, swelling…
Judge in Elizabeth Holmes Case Proposes Texas Prison Camp for Theranos Founder
Tech Holmes was sentenced to more than 11 years in prison in Silicon Valley fraud case
FTC Appeals Judge’s Dismissal of Suit Against Illumina Deal
By Dave Michaels and Peter Loftus Updated Sept. 2, 2022 5:02 pm ET Listen to article…
FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease
The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…
Opinion | The FDA and an ALS Treatment
Few diseases are as cruelly debilitating as amyotrophic lateral sclerosis (ALS). But a Food and Drug…